Clinical Trials List
Protocol NumberPEP0201 PGx
Not yet recruiting
2009-04-25 - 2010-04-25
Others
Terminated1
-
Trial Applicant
PharmaEngine Inc.
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Li-Tzong Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
6 participants
